Sodium Valproate in Patients With Acute Ischemic Stroke
Status:
RECRUITING
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this pilot trial is to investigate the feasibility, safety, and efficacy of sodium valproate in patients with acute ischemic stroke, and also explore the mechanism: whether valproate increases peripheral anti-inflammatory CD177+ neutrophil levels.